BASELINE 4K SCORE PREDICTS PROGRESSION ON ACTIVE SURVEILLANCE IN PROSTATE CANCER INDEPENDENTLY OF CLINICAL INFORMATION AND PIRADS SCORE

被引：0
|
作者：
Hougen, Helen
Reis, Isildinha M.
Prakash, Nachiketh S.
Blachman-Braun, Ruben
Delgado, Jessica
Ritch, Chad R.
Nahar, Bruno
Gonzalgo, Mark L.
Parekh, Dipen J.
Stoyanova, Radka
Gaston, Sandra M.
Kryvenko, Oleksandr
Mahal, Brandon
Abromowitz, Matthew
Dal Pra, Alan
Pollack, Alan
Punnen, Sanoj
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP55-05
引用
收藏
页码：E764 / E765
页数：2
相关论文
共 50 条
  • [21] Clinical application of the PRECISE score for reporting magnetic resonance imaging in men on active surveillance for prostate cancer
    Aerts, J.
    Hendrickx, S.
    Lumen, N.
    Verbeke, S.
    Villeirs, G.
    Van Praet, C.
    De Visschere, P.
    EUROPEAN UROLOGY, 2023, 83
  • [22] mpMRI Interpretation in Active Surveillance for Prostate Cancer-An overview of the PRECISE score
    Harder, Felix N.
    Heming, Carolina A. M.
    Haider, Masoom A.
    ABDOMINAL RADIOLOGY, 2023, 48 (07) : 2449 - 2455
  • [23] CHANGE IN SERIAL BIOPSY GLEASON SCORE IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE
    Greene, Kirsten L.
    Cowan, Janet E.
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 177 - 177
  • [24] Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active Surveillance
    Goss, Louisa B.
    Liu, Menghan
    Zheng, Yingye
    Guo, Boya
    Conti, David V.
    Haiman, Christopher A.
    Kachuri, Linda
    Catalona, William J.
    Witte, John S.
    Lin, Daniel W.
    Newcomb, Lisa F.
    Darst, Burcu F.
    JAMA ONCOLOGY, 2025, 11 (02) : 168 - 171
  • [25] Increasing trend of utilising active surveillance for Gleason Score 7 (3+4) prostate cancer
    Bernardino, Rui
    Sayyid, Rashid K.
    Leao, Ricardo
    Zlotta, Alexandre R.
    van Der Kwast, Theodorus
    Klotz, Laurence
    Fleshner, Neil E.
    BJU INTERNATIONAL, 2023, 132 (06) : 638 - 640
  • [26] Clinical outcomes in men with prostate cancer who selected active surveillance using a clinical cell cycle risk score
    Kaul, Sanjeev
    Wojno, Kirk J.
    Stone, Steven
    Evans, Brent
    Bernhisel, Ryan
    Meek, Stephanie
    D'Anna, Richard E.
    Ferguson, Jeffrey
    Glaser, Jeffrey
    Morgan, Todd M.
    Lieb, Jeremy
    Yan, Robert
    Cohen, Todd
    Ehdaie, Behfar
    PERSONALIZED MEDICINE, 2019, 16 (06) : 491 - 499
  • [27] THE PCA3 SCORE ACCURATELY PREDICTS TUMOR VOLUME AND MIGHT HELP IN SELECTING PROSTATE CANCER PATIENTS FOR ACTIVE SURVEILLANCE
    Ploussard, G.
    Durand, X.
    Xylinas, E.
    Moutereau, S.
    Radulescu, C.
    Forgue, A.
    Terry, S.
    Allory, Y.
    Loric, S.
    Salomon, L.
    Vacherot, F.
    De La Taille, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 313 - 314
  • [28] A NOVEL PREDICTOR OF CLINICAL PROGRESSION IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Tan, Guan Hee
    Finelli, Antonio
    Ahmad, Ardalan Ejaz
    Wettstein, Marian
    Zlotta, Alexandre
    Fleshner, Neil
    Hamilton, Robert
    Kulkarni, Girish
    Ajib, Khaled
    Nason, Gregory
    Perlis, Nathan
    JOURNAL OF UROLOGY, 2019, 201 (04): : E702 - E702
  • [29] A novel predictor of clinical progression in patients on active surveillance for prostate cancer
    Tan, Guan Hee
    Finelli, Antonio
    Ahmad, Ardalan
    Wettstein, Marian S.
    Chandrasekar, Thenappan
    Zlotta, Alexandre R.
    Fleshner, Neil E.
    Hamilton, Robert J.
    Kulkarni, Girish S.
    Ajib, Khaled
    Nason, Gregory
    Perlis, Nathan
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (08): : 250 - 255
  • [30] Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?
    Pham, Duc Minh
    Kim, Jung Kwon
    Lee, Sangchul
    Hong, Sung Kyu
    Byun, Seok-Soo
    Lee, Sang Eun
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (04) : 405 - 410
12345